CS207399B2 - Method of making the derivates of the benzodiazepine - Google Patents

Method of making the derivates of the benzodiazepine Download PDF

Info

Publication number
CS207399B2
CS207399B2 CS772937A CS63380A CS207399B2 CS 207399 B2 CS207399 B2 CS 207399B2 CS 772937 A CS772937 A CS 772937A CS 63380 A CS63380 A CS 63380A CS 207399 B2 CS207399 B2 CS 207399B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
test
benzodiazepine
dose
compounds
Prior art date
Application number
CS772937A
Other languages
Czech (cs)
English (en)
Inventor
Henri Demarne
Andre Hallot
Original Assignee
Clin Midy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Midy filed Critical Clin Midy
Publication of CS207399B2 publication Critical patent/CS207399B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS772937A 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine CS207399B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB18492/76A GB1538164A (en) 1976-05-05 1976-05-05 Benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
CS207399B2 true CS207399B2 (en) 1981-07-31

Family

ID=10113358

Family Applications (3)

Application Number Title Priority Date Filing Date
CS772937A CS207399B2 (en) 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine
CS772937A CS207398B2 (en) 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine
CS772937A CS207400B2 (en) 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine

Family Applications After (2)

Application Number Title Priority Date Filing Date
CS772937A CS207398B2 (en) 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine
CS772937A CS207400B2 (en) 1976-05-05 1977-05-04 Method of making the derivates of the benzodiazepine

Country Status (31)

Country Link
US (2) US4235897A (fr)
JP (3) JPS52156882A (fr)
AR (1) AR219924A1 (fr)
AT (1) AT356655B (fr)
AU (1) AU509147B2 (fr)
BE (1) BE854249A (fr)
CA (1) CA1083146A (fr)
CH (2) CH620686A5 (fr)
CS (3) CS207399B2 (fr)
DD (1) DD129446A5 (fr)
DE (2) DE2719608A1 (fr)
DK (2) DK195077A (fr)
EG (1) EG12724A (fr)
ES (1) ES458481A1 (fr)
FI (1) FI771413A (fr)
FR (2) FR2350345A1 (fr)
GB (1) GB1538164A (fr)
GR (1) GR63203B (fr)
HU (1) HU177573B (fr)
IE (1) IE44830B1 (fr)
IL (2) IL51998A (fr)
MX (1) MX4720E (fr)
NL (2) NL7704911A (fr)
NO (2) NO771560L (fr)
NZ (1) NZ184012A (fr)
PH (1) PH12641A (fr)
PT (1) PT66500B (fr)
SE (2) SE432099B (fr)
SU (1) SU888820A3 (fr)
YU (1) YU41818B (fr)
ZA (1) ZA772628B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2900017A1 (de) * 1978-01-10 1979-07-12 Clin Midy 3-alkoxycarbonyl-benzodiazepin- derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
FR2460938A1 (fr) * 1979-07-12 1981-01-30 Cm Ind Procede d'obtention de benzodiazepines-1,4
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
JPS6038380A (ja) * 1983-08-11 1985-02-27 Shionogi & Co Ltd 1−ピペリジニル−1,4−ベンゾジアゼピン類の改良合成法
JPH04200396A (ja) * 1990-11-30 1992-07-21 Sanwa Kagaku Kenkyusho Co Ltd 過酸化水素の酵素学的高感度測定法及びそのための試薬
AU678503B2 (en) * 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
KR100668045B1 (ko) * 2005-08-17 2007-01-16 한국과학기술연구원 ω-[2-(폴리알킬렌옥시)에틸티오]알킬알콕시실레인유도체와 이의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US28315A (en) * 1860-05-15 Improvement in method of decomposing fats into fatty acids and glycerine
US3136815A (en) * 1959-12-10 1964-06-09 Hoffmann La Roche Amino substituted benzophenone oximes and derivatives thereof
US3236838A (en) * 1964-06-09 1966-02-22 Hoffmann La Roche Certain 1-substituted-benzodiazepin-2-one compounds
USRE28315E (en) 1964-06-15 1975-01-21 Cooc.hi
FR1497456A (fr) * 1964-06-15 1967-10-13 Clin Byla Ets Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et prépaation de ces divers corps
US3812103A (en) * 1967-04-11 1974-05-21 Hoffmann La Roche 2,3-dihydro-1,4-benzodiazepines
CH500997A (de) * 1967-08-09 1970-12-31 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH498846A (de) * 1967-08-09 1970-11-15 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
US3657223A (en) * 1969-01-17 1972-04-18 Hoffmann La Roche Process for the preparation of benzodiazepin-2-one derivatives
DE2008612A1 (de) * 1969-03-13 1970-10-01 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Benzodiazepin-Derivate
US3718646A (en) * 1970-10-05 1973-02-27 Upjohn Co N-lower alkenyl-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepine-1-carboxamides
IT1044223B (it) * 1972-08-09 1980-03-20 Zambeletti Spa L I propargil 1 4 benzodiazepine

Also Published As

Publication number Publication date
DK195077A (da) 1977-11-06
ZA772628B (en) 1978-03-29
FI771413A (fr) 1977-11-06
YU113977A (en) 1982-08-31
CS207400B2 (en) 1981-07-31
US4587245A (en) 1986-05-06
PT66500B (fr) 1978-10-13
AT356655B (de) 1980-05-12
SE7705182L (sv) 1977-11-06
ATA320177A (de) 1979-10-15
FR2350345B1 (fr) 1980-07-18
AU2481377A (en) 1978-11-09
HU177573B (en) 1981-11-28
SU888820A3 (ru) 1981-12-07
CH620912A5 (fr) 1980-12-31
US4235897A (en) 1980-11-25
YU41818B (en) 1988-02-29
IE44830B1 (en) 1982-04-07
MX4720E (es) 1982-08-13
AR219924A1 (es) 1980-09-30
PT66500A (fr) 1977-06-01
ES458481A1 (es) 1978-04-01
NO813180L (no) 1977-11-08
DE2719608A1 (de) 1977-11-24
SE431543B (sv) 1984-02-13
JPS5781472A (en) 1982-05-21
BE854249A (fr) 1977-11-04
PH12641A (en) 1979-07-11
SE432099B (sv) 1984-03-19
FR2350345A1 (fr) 1977-12-02
JPS52156883A (en) 1977-12-27
FR2350346B1 (fr) 1980-11-21
NO149208B (no) 1983-11-28
IL51998A (en) 1981-05-20
IE44830L (en) 1977-11-05
IL51998A0 (en) 1977-07-31
CH620686A5 (fr) 1980-12-15
IL58648A0 (en) 1980-02-29
SE7705183L (sv) 1977-11-06
DD129446A5 (de) 1978-01-18
GR63203B (en) 1979-10-08
JPS5711317B2 (fr) 1982-03-03
JPS52156882A (en) 1977-12-27
JPS6137249B2 (fr) 1986-08-22
DE2719607A1 (de) 1977-11-17
NZ184012A (en) 1981-11-19
DE2719607C2 (fr) 1987-07-16
NL7704911A (nl) 1977-11-08
FR2350346A1 (fr) 1977-12-02
NO149208C (no) 1984-03-07
NL7704912A (nl) 1977-11-08
CA1083146A (fr) 1980-08-05
CS207398B2 (en) 1981-07-31
EG12724A (en) 1979-12-31
NO771560L (no) 1977-11-08
GB1538164A (en) 1979-01-10
DK195177A (da) 1977-11-06
AU509147B2 (en) 1980-04-24

Similar Documents

Publication Publication Date Title
US9133139B2 (en) Fluoroalkyl-1,4-benzodiazepinone compounds
UA117574C2 (uk) Інгібітори котранспортера натрій-глюкози 1
WO2016205739A1 (fr) Dérivés de benzodiazépine, compositions et méthodes de traitement de la déficience cognitive
DE69629618T2 (de) Behandlung von motorischen Fehlfunktionen
CS207399B2 (en) Method of making the derivates of the benzodiazepine
WO2016090317A1 (fr) Dérivés de sulfonamide, compositions et procédés d'utilisation dans le traitement de maladies neurodégénératives
HU191586B (en) Process for preparing new derivatives of pyridazine and pyrimidine
KR880001077B1 (ko) 4-페닐 퀴나졸린 유도체의 제조방법
Larsen et al. Synthesis and hypocholesterolemic activity of 6, 7-dihydro-4H-pyrazolo [1, 5-a] pyrrolo [3, 4-d] pyrimidine-5, 8-diones, novel inhibitors of acylCoA: cholesterol O-acyltransferase
IE911304A1 (en) 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers
JPH0324054A (ja) 学習・記憶力増強のための1―アシル―2―ピロリジノンおよびその組成物
US3313696A (en) Carbamate sedative compositions and method of use
EP0054839B1 (fr) Acylaminométhyl-2 benzodiazépines-1,4, leurs sels, procédé pour leur préparation et médicaments contenant ces composés
US2807617A (en) Acylpiperazines and methods of preparing the same
WO2016090313A1 (fr) Composés, compositions et procédés d'utilisation associés
US3920687A (en) 2,3,6,7-tetrahydro-6-phenyl-5h-imidazo(1,2-d)+8 1,4)benzodiazepin-5-ones and diazepines
DE602004003831T2 (de) 2-ä4-(2-hydroxymethyl-phenylamino)-piperidin-1-ylü-n-(9h-carbazol-3-yl) - acetamid derivate und verwandte verbindungen als neuropeptide y5 (npy5) liganden zur behandlung von fettleibigkeit
RU2655929C1 (ru) Анксиолитическое средство
FI57256C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat
EP0172526B1 (fr) Benzodiazépines, procédé pour leur préparation et leur application
WO1992002498A1 (fr) Composes a activite de stimulation de la cognition, leur procede de preparation et compositions pharmaceutiques les contenant
DE2900017A1 (de) 3-alkoxycarbonyl-benzodiazepin- derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US3639457A (en) N-substituted-beta-oxybutyramide semisuccinate and its salt having effects of increasing paradoxical sleep and tranquillizing
GB1560247A (en) Pharmaceutical compositions
AU655227B2 (en) Substituted benzofuranylpiperidine as a nootropic agent